Japan said Friday it has agreed to receive a supply of 120 million doses of a coronavirus vaccine for 60 million people by the end of June next year from U.S. pharmaceutical giant Pfizer Inc. and its German partner BioNTech SE., if they succeed in developing the vaccine.It is the first time the Japanese government has struck a deal over the supply of a vaccine against the virus that causes the COVID-19 respiratory illness.Related coverage:U.S. firms in final stages of coronavirus vaccine trials8 coronavirus vaccine candidates in clinical trial: WHOREAD FULL ARTICLE